All posts by: Michael Zand

About Michael Zand

What Is Gene Therapy? How Does It Work? – FDA.gov

Continue reading

2017-12-19 NEWS

FDA.gov

What Is Gene Therapy? How Does It Work?
FDA.gov
Gene therapy can be used to modify cells inside or outside the body. When it’s done inside the body, a doctor will inject the vector carrying the gene directly into the part of the body that has defective cells. In gene therapy that is used to modify

and more »

Continue reading

2017-12-19 NEWS

Muscular Dystrophy News

Gene Therapy Approach Using HAC Vector May Work with Dystrophin Gene, Study Suggests
Muscular Dystrophy News
Gene therapy aims to treat DMD, caused by mutations in the dystrophin gene, by delivering the correct version of the gene to patients’ cells to replace the faulty version. But the considerable size of the dystrophin gene makes it difficult for

Continue reading

2017-12-19 NEWS

Singapore’s IP Office to Grant Merck’s Patent Application for CRISPR Technology
AsiaOne
This forthcoming, fundamental patent in Singapore, entitled “CRISPR-BASED GENOME MODIFICATION AND REGULATION,” covers chromosomal integration, or cutting of the chromosomal sequence of eukaryotic cells (such as mammalian and plant cells) and insertion
Singapore’s IP Office to Grant MilliporeSigma’s Patent Application for …PR Newswire (press release)

all 2 news articles »

Continue reading

2017-12-19 NEWS

Singapore’s IP Office to Grant MilliporeSigma’s Patent Application for CRISPR Technology
Canada NewsWire (press release)
“Singapore’s notice of patent allowance for MilliporeSigma’s CRISPR integration technology is yet another reinforcement of our intellectual property,” said Udit Batra, CEO, MilliporeSigma. “We look forward to receiving additional grants for similar

Continue reading

2017-12-19 NEWS

Singapore’s IP Office to Grant MilliporeSigma’s Patent Application for CRISPR Technology
Markets Insider
BURLINGTON, Mass., Dec. 19, 2017 /CNW/ — MilliporeSigma, a leader in genome editing, today announced that the Intellectual Property Office of Singapore has issued a “Notice of Eligibility for Grant” for MilliporeSigma’s patent application covering the
Singapore’s IP Office to Grant Merck’s Patent Application for CRISPR …PR Newswire UK (press release)

all 2 news articles »